In Market Watch, what FactSet defined industry classification do Amgen, Gilead Sciences, and Biogen fall under?

In Market Watch, what FactSet defined industry classification do Amgen, Gilead Sciences, and Biogen fall under?

• A. Pharmaceuticals: Major
• B. Biotechnology
• C. Services to the Health Industry
• D. Pharmaceuticals: Generic

Answer: (B)

Amgen, Gilead Sciences, and Biogen are classified under the Biotechnology industry. This classification is appropriate because these companies primarily focus on developing biopharmaceutical products. Biotechnology typically involves the use of living organisms or biological systems to develop new medications and therapies, which is the core business for these firms. They conduct extensive research and utilize advanced biological techniques to create innovative treatments, distinguishing them from other segments like pharmaceuticals, which may focus more on traditional chemical drugs or generics. While the other classifications may seem relevant, they encompass different aspects of the health industry. For instance, "Pharmaceuticals: Major" and "Pharmaceuticals: Generic" relate specifically to traditional drug manufacturing and product types, which do not fully capture the essence of what these companies do in the realm of biotechnology. "Services to the Health Industry" pertains to companies providing auxiliary services rather than direct involvement in biopharmaceutical development.

Amgen, Gilead Sciences, and Biogen are classified under the Biotechnology industry. This classification is appropriate because these companies primarily focus on developing biopharmaceutical products. Biotechnology typically involves the use of living organisms or biological systems to develop new medications and therapies, which is the core business for these firms. They conduct extensive research and utilize advanced biological techniques to create innovative treatments, distinguishing them from other segments like pharmaceuticals, which may focus more on traditional chemical drugs or generics.

While the other classifications may seem relevant, they encompass different aspects of the health industry. For instance, "Pharmaceuticals: Major" and "Pharmaceuticals: Generic" relate specifically to traditional drug manufacturing and product types, which do not fully capture the essence of what these companies do in the realm of biotechnology. "Services to the Health Industry" pertains to companies providing auxiliary services rather than direct involvement in biopharmaceutical development.